Form 8-K HERON THERAPEUTICS, INC. For: Aug 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval
August 10, 2016 12:50 PM EDTBelow is the FDA's approval letter Heron Therapeutics' (Nasdaq: HRTX) SUSTOL:
... MoreFDA Approval of Heron Therapeutics' (HRTX) Sustol Removes Major Overhang - Analyst
August 10, 2016 11:14 AM EDTLeerink affirms Heron Therapeutics (Nasdaq: HRTX) at Outperform with a price target of $33 following FDA approval of Sustol for treatment of chemo induced nausea and vomiting.
Analyst Jason Gerberry commented today: We are still reviewing the package insert, but Sustol... More



